SMLR Stock Overview
Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Semler Scientific, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$71.84 |
| 52 Week High | US$79.45 |
| 52 Week Low | US$20.88 |
| Beta | 1.18 |
| 1 Month Change | 36.29% |
| 3 Month Change | 177.16% |
| 1 Year Change | 56.96% |
| 3 Year Change | -23.54% |
| 5 Year Change | 57.03% |
| Change since IPO | 927.75% |
Recent News & Updates
Recent updates
Semler Scientific: Booking Some Profits After Bitcoin Strategy
Dec 10Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%
Nov 02
Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders
Aug 14The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet
Jul 18We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease
May 08Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)
Apr 17Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?
Jan 11Estimating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)
Dec 07What Does Semler Scientific, Inc.'s (NASDAQ:SMLR) Share Price Indicate?
Apr 07Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)
Dec 14Semler Scientific: Growth, Profits, And Valuation Models Support A Buy
Aug 02Semler Scientific: A Small Company Solving A Big Problem
Apr 21Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade
Mar 08Semler Scientific: Why I'm Buying
Mar 05Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?
Mar 02Semler's Unique Business Model Is Fueling Profitable Growth
Feb 23Better Price For Semler Is Likely
Jan 05Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They Seem
Nov 12Shareholder Returns
| SMLR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 22.7% | -1.4% | -0.2% |
| 1Y | 57.0% | 14.6% | 28.8% |
Return vs Industry: SMLR exceeded the US Medical Equipment industry which returned 14.6% over the past year.
Return vs Market: SMLR exceeded the US Market which returned 28.8% over the past year.
Price Volatility
| SMLR volatility | |
|---|---|
| SMLR Average Weekly Movement | 18.2% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SMLR's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: SMLR's weekly volatility has increased from 13% to 18% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 92 | Doug Murphy-Chutorian | www.semlerscientific.com |
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing.
Semler Scientific, Inc. Fundamentals Summary
| SMLR fundamental statistics | |
|---|---|
| Market cap | US$534.86m |
| Earnings (TTM) | US$15.91m |
| Revenue (TTM) | US$58.94m |
37.4x
P/E Ratio10.1x
P/S RatioIs SMLR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMLR income statement (TTM) | |
|---|---|
| Revenue | US$58.94m |
| Cost of Revenue | US$7.04m |
| Gross Profit | US$51.90m |
| Other Expenses | US$35.98m |
| Earnings | US$15.91m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.92 |
| Gross Margin | 88.05% |
| Net Profit Margin | 27.00% |
| Debt/Equity Ratio | 0% |
How did SMLR perform over the long term?
See historical performance and comparison